About Qualigen

Qualigen, Inc. develops, manufactures and markets the new FastPack^® IP System, the first custom-designed analyzer which features one-touch operation to perform complex quantitative immunoassays quickly and easily in the physician's office lab.

The following assays are now cleared by the FDA: Thyroid Stimulating Hormone (TSH), free Thyroxine (freeT4), Human Chorionic Gonadotropin (hCG), Total Prostate Specific Antigen (tPSA) and Testosterone. Free PSA is available outside the United States. The success of the FastPack^® System in the Urology field, coupled with the addition of thyroid function assays, has opened the door to market the system to the following additional medical specialties: Family Practice, Internal Medicine, Urgent Care, OB/GYN and Endocrinology.

Corporate Officers

Paul A. Rosinack
President & CEO, Director

Michael S. Poirier
Senior Vice President, Chief Scientific & Technical Officer

Christopher L. Lotz
Vice President, Chief Financial Officer

Robert D. Buchanan
Vice President, Sales and Marketing

Shishir K. Sinha
Vice President, Operations

Wajdi Abdul-Ahad, MSc, MBA, PhD
Vice President, Assay Development

Board of Directors

Paul A. Rosinack
President & CEO, Qualigen, Inc.

Paulita M. LaPlante
President & CEO, väsamed, Inc.

Michael J. Spalding, M.D.
Partner, The Center for Urological Treatment, PLLC

Features

• One Touch Operation
• Results in Minutes
• Lab Quality Precision
• Increased Revenue
• Patient Side Testing
• Increase Office Efficiency